Unknown

Dataset Information

Aggressive anticancer treatment in the last 2 weeks of life.


ABSTRACT:

Background

There is a concern that terminally ill cancer patients may be aggressively treated due to the rapidly growing possibilities of anticancer treatment. The aim of this study was to evaluate the use of anticancer treatment at the end of life (EoL).

Materials and methods

This retrospective study included adult patients with advanced solid cancers who were treated at the Institute of Oncology Ljubljana and died of cancer between January 2015 and December 2019. A multiple logistic regression model was used to assess an association between the aggressiveness of anticancer treatment (i.e. systemic therapy, radiotherapy and surgery) in the last 2 weeks of life and year of death, age at death, sex, prognosis of cancer and enrolment into the specialist palliative care (SPC).<

SUBMITTER: Golob N 

PROVIDER: S-EPMC10944113 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature